ArticlePlanta2026
Cytokinin response factor 1 acts as a negative regulator of cytokinin-mediated developmental pathways in Arabidopsis.
Article in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
MAIN
conclusionCRF1 functions as a negative regulator of cytokinin signaling in Arabidopsis at least in part by antagonizing ARR12-dependent SHY2 transactivation, thereby influencing primary root growth, rosette development, and leaf senescence. Cytokinin Response Factors (CRFs) are members of the AP2/ERF family of transcription factors that act downstream of the two-component cytokinin signaling pathway to regulate diverse developmental processes. In this study, we identify CRF1 as a negative regulator of cytokinin signaling in Arabidopsis thaliana. Loss-of-function crf1 mutants exhibit pronounced hypersensitivity to cytokinin, characterized by stronger inhibition of primary root growth, larger rosette size, and delay in dark-induced leaf senescence, compared to wild type. Conversely, when CRF1 was overexpressed (CRF1-OX), it impaired cytokinin-induced responses in both primary root and shoot. These phenotypic alterations in response to cytokinin correlated with transcriptional changes. At the transcript level, primary cytokinin-inducible genes, like type-A and type-B ARRs, and secondary responsive genes like SHY2, were significantly upregulated in crf1 mutants in response to cytokinin, compared to wild type. SHY2 is a known Aux/IAA protein that works to repress auxin signaling, especially in primary roots. Interestingly, while the type-B ARR, ARR12, is known to transactivate SHY2 promoter, our results show that its activity is impaired in presence of CRF1. Transactivation assays clearly indicated that ARR12 could not activate SHY2 promoter when present along with CRF1, implying that CRF1 intercepts ARR12-mediated transcriptional regulation. CRF1 thus acts as a negative regulator of cytokinin signaling, acting at least in part by antagonizing ARR12-mediated gene expression. In summary, CRF1 modulates key developmental processes in Arabidopsis by regulating cytokinin responses in both primary root and shoot, and may serve as a potential target for fine-tuning plant growth and development.
Indexed as
Identifiers
41811503What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.